News | September 22, 2023
Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma for Rs. 5,652 Cr
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
InvaGen has received 5 inspectional observations in Form 483
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
Subscribe To Our Newsletter & Stay Updated
